Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The role of hormone replacement therapy in breast cancers detected between screenings

20.03.2002


Research from the Cancer Registry of Norway has revealed that a higher proportion of women who discover they have breast cancer between mammographic screenings have also used HRT (hormone replacement therapy) at some point in their lives, the 3rd European Breast Cancer Conference heard today (Wednesday 20 March). In addition, these women tend to have denser breasts, and this may be why their tumours were not detected during screening.



Mrs Hege Wang, a researcher at the Cancer Registry of Norway, told the conference in Barcelona that these findings come from a study set up to examine the association between cancers found between screenings (interval cancers), breast density and the reported use of HRT. Although it is already known that the use of HRT can make breasts denser, this study found that more HRT users than expected had dense breasts, and that interval cancers were detected more frequently than expected amongst women who had used HRT.

Breast density was divided into three categories: lucent (where there was less than 30% glandular tissue - the least dense), intermediate (30-70% glandular tissue), and dense (more than 70% glandular tissue). Six radiologists were asked to scrutinize a mixed set of mammograms which consisted of subsequent interval cancers, screening normal, and screening detected cancers. Information about whether the women had ever used HRT was collected by questionnaire.


The radiologists made some significant findings. Women who had ever used HRT were more likely to have dense breasts and to have cancers detected between screenings, while women who had never used HRT were more likely to have lucent breasts and either to have normal screenings or for tumours to be detected by mammography.

Mrs Wang reported: “Our finding that interval cancers are associated with dense breasts and the use of HRT underlines how the efficacy of screening can be affected by high breast density and HRT.”

Emma Mason | alphagalileo
Further information:
http://www.fecs.be/Conferences/ebcc3

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>